🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The hypothesis of this study is that 96 weeks of Rosuvastatin will be safe ...
Status
Completed
Location
University Hospitals of Cleveland Case Medical Center
Start Date
2011-02
Trial ID
NCT01218802
Treatments Being Tested
Primary Objective: To demonstrate the superiority of the single pill combi...
Status
Completed
Location
Investigational Site Number :1560033
Start Date
2020-12-08
Trial ID
NCT04669041
Treatments Being Tested
This study will evaluate the efficacy and safety and tolerability of 2 dose...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-09
Trial ID
NCT02741245
Treatments Being Tested
The goal of this double-blind randomized controlled trial is to determine h...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2023-12-07
Trial ID
NCT05850091
Treatments Being Tested
This study is a phase III, prospective, placebo-controlled randomized clini...
Status
Recruiting
Location
Unidade de Saúde Santa Cecília / Hospital de Clínicas de Porto Alegre
Start Date
2021-12-20
Trial ID
NCT05155137
Treatments Being Tested
The CHAT Pilot Trial is designed to compare rosuvastatin against placebo in...
Status
Terminated
Location
St. Michael's Hospital
Start Date
2009-12
Trial ID
NCT01798602
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Simbec-Orion Clinical Pharmacology
Start Date
2021-05-13
Trial ID
NCT04931147
Treatments Being Tested